Consolidated Balance Sheet

€ million	Note	Dec. 31, 2014	Dec. 31, 2013

Current assets
Cash and cash equivalents	→ 35	2,878.5	980.8
Current financial assets	→ 36	2,199.4	2,410.5
Trade accounts receivable	→ 37	2,235.6	2,021.4
Inventories	→ 38	1,659.7	1,474.2
Other current assets	→ 39	1,210.2	360.7
Income tax receivables	→ 40	297.0	109.8
Assets held for sale	→ 4	–	27.1
		10,480.4	7,384.5
Non-current assets
Intangible assets	→ 41	11,395.5	9,867.2
Property, plant and equipment	→ 42	2,990.4	2,647.2
Non-current financial assets	→ 43	94.4	77.8
Other non-current assets	→ 39	56.5	105.5
Deferred tax assets	→ 32	992.9	736.4
		15,529.7	13,434.1

Total assets		26,010.1	20,818.6

Current liabilities
Current financial liabilities	→ 44	2,075.9	440.4
Trade accounts payable	→ 45	1,539.4	1,364.1
Other current liabilities	→ 46	1,574.6	1,134.5
Income tax liabilities	→ 47	849.8	465.1
Current provisions	→ 48	561.7	494.7
Liabilities directly related to assets held for sale		–	–
		6,601.4	3,898.8
Non-current liabilities
Non-current financial liabilities	→ 44	3,561.1	3,257.5
Other non-current liabilities	→ 46	782.0	5.6
Non-current provisions	→ 48	626.1	1,011.1
Provisions for pensions and other post-employment benefits	→ 49	1,820.1	910.9
Deferred tax liabilities	→ 32	818.4	665.5
		7,607.7	5,850.6
Equity	→ 50
Equity capital		565.2	565.2
Reserves		9,038.9	9,341.1
Gains/losses recognized immediately in equity		2,137.5	1,113.7
Equity attributable to Merck KGaA shareholders		11,741.6	11,020.0
Non-controlling interests		59.4	49.2
		11,801.0	11,069.2

Total liabilities and equity		26,010.1	20,818.6

Nach oben